|

albumin paclitaxel, cispatin, tislelizumab Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Lai-ping Zhong1

Indications

  • Locally Advanced Head and Neck Carcinoma1
  • Oral Squamous Cell Carcinoma1
  • Cancer1

Other1 trial

Neoadjuvant Immunochemotherapy for LAOSCC
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.